Publicly-traded company Replimune Group Inc. (NASDAQ:REPL) had a closing price of $13.68 yesterday. Meanwhile, the average 12-month price target from Wall Street analysts is currently $28.57, this means that the stock is underpriced by 52.12%. In the past 52 weeks the company’s stock price has moved within the range of $8.88 to $18.25.
This particular stock’s 5-day moving average is 13.81, its 20-day moving average is 14.42 and its 100-day moving average is 13.06. Replimune Group Inc. (REPL) currently has 34.58M shares outstanding, which means that its market capitalization is $473.05M.
The Details: Replimune Group Inc. (REPL) Financial Health
Return on Assets is a number, expressed as a percentage that tells us how well a publicly-traded company is using its current assets to generate revenue. The higher the percentage, the better a company is using its assets to turn a profit. At the moment, Replimune Group Inc. Return on Assets is -23.30%.
What Does Wall Street Say about Company?
When choosing stocks, many investors search for what Wall Street professionals think about the company first – like what the average rating is. At the moment, the average analyst rating for REPL is Buy. Out of 7 total analysts who were surveyed, 0 rated it a sell, 0 rated it a underweight, 0 rated it an overweight, 0 rated it hold, and 7 rated it a Buy.
Three months ago, on the other hand, the average analyst rating for Replimune Group Inc. (REPL) was a Buy – from a survey of 2 analysts. Of the analysts who provided ratings, 0 rated the company a Hold, 0 rated it a Sell, 0 rated it an overweight, 0 rated it an underweight, and 2 rated it a Buy.
Understanding Profitability at Replimune Group Inc. (REPL)
Taking a look at a public company’s Earnings per Share (EPS) is a good way of evaluating its profitability. In the most recent financial results released by Replimune Group Inc., for the quarter ending on 12/2019, the company posted EPS of -0.37. The average estimate of Wall Street analysts had projected -0.31.
Wall Street analysts, on average, are forecasting the company’s EPS to be -0.36, compared to -0.24 reported in the same quarter last year.